Dr. Dan E Arking's lab at Johns Hopkins University focuses on understanding how mitochondria affect human health, especially in relation to aging and diseases like cardiovascular issues and dementia. They study the role of mitochondrial DNA and its variations, aiming to identify biomarkers and therapeutic targets that could improve health outcomes. Their research combines genetics, multi-omics data, and advanced methodologies to uncover insights into mitochondrial function and its implications for diseases.

Dr. Jill A. Fahrner's lab focuses on understanding the genetic and epigenetic factors that lead to growth and neurodevelopmental disorders in children. They study specific conditions known as Weaver and Sotos syndromes, which are characterized by excessive growth and intellectual disabilities. By using a combination of animal models and human cell models, the lab aims to uncover the underlying mechanisms of these diseases and explore new therapeutic options to improve patient outcomes.

Dr. Gregory A. Newby’s lab at Johns Hopkins University focuses on developing advanced genome editing techniques to treat rare genetic diseases. Their research aims to create versatile tools that can address a wide range of rare genetic variants, making treatment options more accessible for patients. By improving the delivery methods of these genome editing therapies, the lab hopes to enhance their safety and effectiveness.

Dr. Andrew S. Mccallion's lab at Johns Hopkins University focuses on understanding how genetic variations in noncoding DNA affect the risk and progression of Parkinson's disease (PD). They aim to investigate the regulatory changes in brain cells that contribute to PD by studying gene regulation and expression in dopamine neurons. Through advanced computational and experimental techniques, the lab seeks to uncover the mechanisms that link genetic factors to disease outcomes, which could inform future treatments and interventions.

Dr. Hilary Vernon's lab at Johns Hopkins University focuses on understanding how mitochondrial function and quality control are regulated in heart cells, particularly in relation to Barth Syndrome. This research is critical because disruptions in mitochondrial maintenance can lead to serious heart problems. By exploring the effects of a specific genetic deficiency, her lab aims to uncover the underlying mechanisms of heart disease and develop potential new therapies.

Dr. Nara Sobreira's lab focuses on studying Ollier disease and Maffucci syndrome, two rare conditions linked to cancer susceptibility. The lab investigates the genetic factors and biological pathways that lead to these diseases, aiming to develop new treatments for patients. By examining the phenotypic features, genetic variants, and their impact on a specific cancer-related pathway, the lab seeks to provide insights that could enhance diagnosis and therapy for these and related cancers.

Dr. David L. Thomas's lab at Johns Hopkins University focuses on understanding liver diseases, particularly hepatitis C (HCV) and steatotic liver disease, especially in people who inject drugs and those living with HIV. The lab investigates the causes and trends of these diseases, aiming to inform public health policies and improve treatment outcomes. Through this research, the lab seeks to address the growing health crisis related to liver disease in vulnerable populations.